Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Dumber in English? | Main | A Real Genetic Headscratcher »

November 9, 2007

One Year

Email This Entry

Posted by Derek

I was reminded yesterday that today is the one-year anniversary of the day that we found out that the Wonder Drug Factory was being closed down. I remember that presentation rather well. I was one of the more optimistic ones, thinking until the last that we had about a 50/50 chance of the ax, but by the time the meeting began everyone had heard what was really coming.

Unpleasant, that was, and it did extend a cloud over the following holiday season. The job-searching period that followed wasn't anything I'm looking to relive, either, although my severance pay kept it from being anywhere near as bad as it could have been. And in the end, things worked out well. I thought they would, but as my wife pointed out to me at the time, I generally think that things will work out well, so that isn't as good an indicator as it might otherwise be.

But the whole thing was a useful reminder: no one's sitting back in a comfortable chair in this industry. You're riding a wild animal, instead. Working at a smaller company makes it easier to remember that, as many people here around the Boston/Cambridge area know, but there's no drug company so large or so profitable that it can make any guarantees to anyone. Patents expire, companies get taken over, drugs drop out of clinical trials or get pulled off the market.

But on the flip side, discoveries get made. Things make it through trials even though no one thought they might. New ideas get tried out, and given how little we know, just about anything has a chance of improving our lot in research. That's the thing about science: we don't have to be stuck where we are; we can invent doors and walk out of them into something new.

Comments (4) + TrackBacks (0) | Category: Drug Industry History | Who Discovers and Why


COMMENTS

1. Wavefunction on November 9, 2007 5:25 PM writes...

Isn't Novartis doing relatively well compared to some of these other big companies (read Pfizer)?

Permalink to Comment

2. LNT on November 9, 2007 10:04 PM writes...

For those of you who have been through layoffs, what is typical for a severance package? Is it based on your years of service? Is it different for PhD vrs. MS/BS, right? (I would hope so since it's clearly harder to find a job as a PhD chemist)
Just morbidly curious in case it ever happens to me....

Permalink to Comment

3. anon on November 10, 2007 9:27 AM writes...

Yes, Derek is right about not getting too comfortable in one place. I went through the last round of "rebound" with Derek, and am currently "at risk" of being laid off again. I spent the past week filling out HR paperwork to reapply for my current job.

Each theraputic area is treated as a seperate business group by my current employer, so you have to go through the formal interviewing process again to switch to another theraputic area. I was granted an internal interview for next week, which I am in the process of preparing for. I won't find out if I have an offer until after things are settled in my current department (early december). It seemed that my current department is going to lose the highest number of people, and we are a satellite site for a much larger site overseas. There is a little less risk in other groups.

Thanks to all of my former WDC colleagues who provided job search information to me. Depending on how things turn out here, I may be sending resumes to you soon.

LNT - Industry standard seems to be two weeks of pay for every year served with a minimum of a certain number of weeks, but this may vary. Director level PhD's probably get a MUCH nicer package, but I don't think that the lower level PhDs are treated any differently than a MS. (Well, your base salary is obviously higher so you would get more money that way, but it is still the 2 weeks/year served.) Please feel free to correct me if I am wrong.

Permalink to Comment

4. John Spevacek on November 12, 2007 9:35 AM writes...

As was said when I was commiserating with a fellow laid-off employee, "We're all contact employees - we just don't know how long the contract is." I can imagine Kafka would write a wonderful short novel if he were still around.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Amicus Fights Its Way Through in Fabry's
Did Pfizer Cut Back Some of Its Best Compounds?
Don't Optimize Your Plasma Protein Binding
Fluorinated Fingerprinting
One of Those Days
ChemDraw Days
Incomprehensible Drug Prices? Think Again.
Proteins Grazing Against Proteins